Muscular dystrophy and trained immunity
Basil Petrof, MD, and his research team, have uncovered a new mechanism of inflammation in muscular dystrophy, paving the way for the development of new therapies.
View his faculty profile here: Maziar Divangahi, PhD
Associate Professor, Department of Medicine, McGill University
Associate Director, Meakins-Christie Laboratories
Research Theme: Host defense against pulmonary pathogens; regulation of death program in macrophages
Keywords: innate and adaptive immunity • influenza virus • mycobacterium tuberculosis • cell death program
View Maziar Divangahi’s recent posts and news below.
Basil Petrof, MD, and his research team, have uncovered a new mechanism of inflammation in muscular dystrophy, paving the way for the development of new therapies.
Congratulations to Jeffrey Downey, PhD student of Dr. Divangahi, recipient of the Gordon A. Maclachlan Convocation Prize.
Alexander Grant, MSc student in Dr. Divangahi’s lab, advocates for others to be prioritized for a COVID-19 vaccine.
Congrats to Maziar Divangahi and Faiz Ahmad Khan on their Fall 2020 Project Grants and Benjamin M Smith on his COPD Catalyst Grant
Dr. Maziar Divangahi on how flu vaccines can help train our body’s immunity to fight the COVID-19 virus.
Congratulations to Dr. Nargis Khan and Jeffrey Downey from the Divangahi lab on their recent publication in Cell!
Could Dr. Divangahi’s expertise in innate disease tolerance be applied to the SARS CoV-2 virus, enabling us to co-exist?
Dr. Divangahi discusses ongoing studies that examine whether flu vaccines may inhibit COVID-19.
The Royal Society of Canada announces Dr. Maziar Divangahi as one of its newest members to the College of New Scholars
Dr. Irah King discusses disease tolerance in light of the recent COVID-19 pandemic and why some weather the infection unscathed